Purchases and Sales Made in Q3 2022 in Fate Therapeutics Inc (FATE)
This table provides information about the institutional ownership of Fate Therapeutics Inc (FATE) during Q3 2022. The information is specifically focused on institutions that hold shares of FATE THERAPEUTICS INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-221K- 26.83% |
$4.64M - $7.95M
|
601K
$692K
|
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-255K- 15.67% |
$5.36M - $9.18M
|
1.37M
$1.58M
|
|
|
Nov 14, 2022
Q3 2022
|
Westfield Capital Management CO LP
Boston, MA |
SELL
|
- |
-403K- 22.46% |
$8.48M - $14.5M
|
1.39M
$1.6M
|
|
|
Nov 14, 2022
Q3 2022
|
Eversept Partners, LP
New York, NY |
SELL
|
- |
-585K- 80.52% |
$12.3M - $21.1M
|
142K
$163K
|
|
|
Nov 08, 2023
Q3 2022
|
Eversept Partners, LP
New York, NY |
SELL
|
- |
-585K- 80.52% |
$12.3M - $21.1M
|
142K
$163K
|
|
|
Nov 14, 2022
Q3 2022
|
Deep Track Capital, LP
Greenwich, CT |
SELL
|
- |
-707K- 35.03% |
$14.9M - $25.5M
|
1.31M
$1.51M
|
|
|
Nov 15, 2022
Q3 2022
|
State Street Corp
Boston, MA |
SELL
|
- |
-888K- 16.84% |
$18.7M - $32M
|
4.38M
$5.04M
|
|
|
Nov 14, 2022
Q3 2022
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-1.84M- 36.96% |
$38.8M - $66.4M
|
3.14M
$3.61M
|